Clearstead Trust’s Enovis ENOV Stock Holding History

Clearstead Trust’s Portfolio ENOV Stock Details ENOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-29	Closed	-$880	–	1167
2025 Q3	$880	Hold	29	–	–	﹤0.01%	1248
2025 Q2	$910	Buy	+29	New	+$959	﹤0.01%	1196

Other funds holding ENOV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

DAM

Dorsey Asset Management Chicago, Illinois $1.56B AUM 25.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Clearstead Trust's ENOV Position: Q4 2025 in Review

Clearstead Trust sold out of Enovis (ENOV) in Q4 2025, closing a stake of 29 shares — an estimated $880 sold.

Clearstead Trust first reported a position in ENOV in Q2 2025 and held it in 2 quarters. The position peaked at $910 in Q2 2025. 254 funds tracked by Wall St. Rank hold ENOV as of Q4 2025.

Clearstead Trust reported no remaining Enovis position as of Q4 2025 after selling out during the quarter.
Clearstead Trust sold 29 Enovis shares in Q4 2025, an estimated $880.
Clearstead Trust first reported a position in Enovis in Q2 2025 and held it in 2 quarters.
Clearstead Trust's Enovis position peaked at $910 in Q2 2025.
254 funds tracked by Wall St. Rank held Enovis as of Q4 2025.

Based on Clearstead Trust's 13F filing for Q4 2025, filed 9 Feb 2026.